Answers are grounded in this paper and cite their sources.
Background National death-certificate co-certification of J84-coded interstitial lung disease (ILD) with deaths attributed to intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH) has not been characterized. We quantified this coding-defined intersection in the United States. Methods We performed a serial cross-sectional analysis of CDC WONDER Multiple Cause of Death data for 1999–2024. Deaths were included when I60 or I61 was the underlying cause and J84 was listed as a multiple cause. Primary estimands were the aggregate co-certification proportion and hemorrhage-subtype distribution. A 95% Wilson confidence interval was calculated for the overall co-certification proportion. Segmented Poisson modeling was limited to the complete combined J84 series; series with suppressed annual cells were not trend-modeled because suppression is informative. Results Among 604,331 U.S. deaths attributed to SAH or ICH, 551 carried J84, an aggregate co-certification proportion of 0.091% (95% CI, 0.084%–0.099%); 437 were ICH and 114 were SAH. The combined crude population mortality rate was 0.050 per 1,000,000 in 1999 and 0.100 in 2024. A secondary exploratory model of the complete combined J84 series selected a 2012 change point, but this model used the U.S. population rather than annual fatal SAH/ICH deaths as its denominator. J84.1 accounted for 410 co-certified deaths (74.4%); its annual trend was not modeled because the 2009 cell was suppressed. SAH-specific, sex-interaction, and exact COVID-exclusion trends were not estimable. Conclusions J84-coded ILD was rarely co-certified among deaths attributed to SAH or ICH. These data provide a national surveillance baseline with a precisely estimated but very small aggregate co-certification proportion. Secondary crude population-rate trends do not measure annual ILD representation among fatal hemorrhagic-stroke deaths, and subgroup trends with suppressed years were not estimated.
No takes yet. Share an insight, caveat, or question.
Cacoulidis et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: